Table 2 Characteristics of the 9 patients of the Hendaye’s cluster
Patient | Genetic | BMI | Comorbidities | Treatments at the time of infection | Clinical signs | Treatments of COVID-19 | |||
|---|---|---|---|---|---|---|---|---|---|
Age | Subtype | (kg/m2) | Anticoagulants | O2 | Antibiotics | Corticosteroids | |||
P1; 45 years | Deletion | 61.7 | T2D; Hypertension; sleep apnea syndrome; Respiratory and cardiac failure; Lower limbs edema; past venous thrombotic events | Thyroxine Antidiabetics Antihypertensives | Fever, asthenia, headache, cough, shortness of breath, oxygen desaturation | Enoxaparin 0.6 ml * 2/day | Yes | amoxicillin/ clavulanic acid 1 g * 3 /day | DXM 6 mg/day for 12 days |
P2; 60 years | Deletion | 57.9 | T2D; Hypertension; sleep apnea syndrome; Respiratory failure; Lower limbs edema; past venous thrombotic events | Thyroxine Vitamin D Antidiabetics Antihypertensives | Cough, shortness of breath | Enoxaparin 0.6 ml * 2/day | Yes | amoxicillin/ clavulanic acid 1 g * 3 /day | DXM 6 mg/day for 12 days |
P3; 40 years | Deletion | 70.8 | Hypertension; sleep apnea syndrome; Respiratory and cardiac failure; Lower limbs edema; past venous thrombotic events | Thyroxine Vitamin D Antihypertensives Anxiolytics | Cough, headache, shortness of breath | Enoxaparin 0.6 ml * 2/day | Yes | No | No |
P4; 22 years | Deletion | 47.7 | T2D; sleep apnea syndrome; Respiratory failure; Lower limbs edema | Thyroxine Antidiabetics Topiramate Antipsychotics | Fever, asthenia, shortness of breath | Enoxaparin 0.4 ml * 2/day | No | No | No |
P5; 42 years | Deletion | 39.9 | T2D; Hypertension; Sleep apnea syndrome; Lower limbs edema | Antidiabetics Antihypertensives Lipid lowering therapy Topiramate; antidepressants | Cough shortness of breath | Enoxaparin 0.4 ml * 2/day | No | No | No |
P6; 33 years | UPD | 32.0 | Vitamin D Antipsychotics; mood stabilisers | Fever, cough | Enoxaparin 0.4 ml * 2/day | No | No | No | |
P7; 21 years | Deletion | 44.0 | T2D | GH; SHT; Thyroxine Antidiabetics Antipsychotics Antidepressants; Anxiolytics | Asymptomatic | Enoxaparin 0.4 ml * 2/day | No | No | No |
P8; 52 years | Deletion | 31.5 | Vitamin D | Asymptomatic | Enoxaparin 0.4 ml * 2/day | No | No | No | |
P9; 29 years | Deletion | 26.4 | GH; SHT; Thyroxine Vitamin D | Asymptomatic | Enoxaparin 0.4 ml * 2/day | No | No | No | |